Skip to main page content

Canadian Treat-and-Extend Trial with Ranibizumab in nAMD Patients: CANTREAT 36-month Extension Results

My Session Status

What:
Paper Presentation | Présentation d'article
When:
14:05, sábado 27 jun 2020 (10 minutos)
Theme:
Retina

My Session Status

Send Feedback